Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Organisation › Details

Ochre Bio Ltd.

Ochre Bio is a biotechnology company developing RNA medicines for chronic liver diseases, a top ten global killer. We uncover new biological pathways by using advances in 'deep phenotyping', and then study our medicines in human livers kept alive on machines. In doing so, Ochre Bio ensures that the medicines we bring to the clinic are highly likely to successfully improve patient lives. Situated within the heart of Oxford’s biotech innovation hub, Ochre is built on over 15 years experience in liver genomics and bringing advanced therapies to market. *

 

Period Start 2019-11-04 established
Product Industry BIOTECH
Person Person O’Meara, Jack (Ochre Bio 202106 CEO + Co-Founder)
     
Region Region Headington, Oxfordshire
  Country United Kingdom (GB)
  Street Roosevelt Drive
BioEscalator, Innovation Building
  City OX3 7FZ Headington, Oxford
    Address record changed: 2021-07-10
     
Basic data Employees n. a.
     
    * Document for �About Section�: Ochre Bio Ltd.. (6/16/21). "Press Release: Ochre Bio Closes $9.6M Seed Financing Led by Khosla Ventures". Oxford.
     
   
Record changed: 2021-06-18

Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for Ochre Bio Ltd.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Demy-Colton BioFuture 2021 NYC D Meet Top Investors 650x300px




» top